Labcorp Holdings Inc. (LH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LH Revenue Growth
Revenue Breakdown (FY 2025)
LH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
LH Revenue Analysis (2014–2025)
As of May 7, 2026, Labcorp Holdings Inc. (LH) generated trailing twelve-month (TTM) revenue of $14.14 billion, reflecting solid growth of +5.8% year-over-year. The most recent quarter (Q1 2026) recorded $3.54 billion in revenue, up 0.6% sequentially.
Looking at the longer-term picture, LH's 5-year compound annual growth rate (CAGR) stands at -0.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $13.98 billion in 2020.
Revenue diversification analysis shows LH's business is primarily driven by LabCorp Diagnostics (100%). With over half of revenue concentrated in LabCorp Diagnostics, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including DGX (+11.0% YoY), SLNO, and EXAS (+17.7% YoY), LH has underperformed the peer group in terms of revenue growth. Compare LH vs DGX →
LH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LHCurrent | $14.1B | +5.8% | -0.0% | 10.9% | |
 DGX | $11.0B | +11.0% | +3.2% | 14.5% | |
 SLNO | $190M | - | - | 7.9% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 BIO | $2.6B | +1.9% | +0.3% | 10.5% | |
 NTRA | $1.7B | +38.2% | +41.2% | -13.1% |
LH Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $13.95B | +7.2% | $3.73B | 26.8% | $1.52B | 10.9% |
| 2024 | $13.01B | +7.0% | $3.62B | 27.9% | $1.09B | 8.4% |
| 2023 | $12.16B | +2.5% | $3.36B | 27.7% | $725.6M | 6.0% |
| 2022 | $11.86B | -9.7% | $3.71B | 31.3% | $1.44B | 12.1% |
| 2021 | $13.14B | -6.0% | $4.99B | 38.0% | $3.05B | 23.2% |
| 2020 | $13.98B | +21.0% | $4.95B | 35.4% | $2.45B | 17.5% |
| 2019 | $11.55B | +2.0% | $3.25B | 28.1% | $1.33B | 11.5% |
| 2018 | $11.33B | +8.5% | $3.18B | 28.0% | $1.33B | 11.7% |
| 2017 | $10.44B | +8.3% | $3.46B | 33.2% | $1.36B | 13.1% |
| 2016 | $9.64B | +11.1% | $3.18B | 33.0% | $1.31B | 13.6% |
Full LH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See LH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLH — Frequently Asked Questions
Quick answers to the most common questions about buying LH stock.
Is LH's revenue growth accelerating or slowing?
LH maintains +5.8% revenue growth, in line with its 5-year CAGR of -0.0%. TTM revenue stands at $14.1B. Growth rate remains consistent with historical average.
What is LH's long-term revenue growth rate?
Labcorp Holdings Inc.'s 5-year revenue CAGR of -0.0% reflects the sustained expansion pattern. Current YoY growth of +5.8% is near this long-term average.
How is LH's revenue distributed by segment?
LH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.